Glycated hemoglobin: sugar control over the past months

Glycated hemoglobin, also known as hemoglobin A1c, is the portion of red blood cell hemoglobin bound to glucose. The higher the blood glucose concentration, the more hemoglobin molecules are glycated. Therefore, the test does not show a single blood sugar level, but rather the average blood glucose level over the previous 2-3 months, with the main contribution coming from the final weeks before the test. [1]

The main value of this test is that it is less susceptible to short-term fluctuations than fasting glucose measurements or a stress test. Blood sugar on a given day is affected by stress, exercise, infection, sleep deprivation, and other temporary factors, whereas glycated hemoglobin reflects a more stable picture of glucose metabolism. This is why it has become the primary laboratory marker for long-term diabetes management. [2]

This indicator is important not only for detecting hyperglycemia but also for predicting complications. Higher glycated hemoglobin levels are associated with a greater risk of long-term vascular complications of diabetes, primarily damage to the retina, kidneys, and nervous system. Current diabetes guidelines clearly indicate that lowering glycated hemoglobin improves long-term outcomes. [3]

However, glycated hemoglobin cannot be considered an ideal universal indicator. It does not show daily fluctuations in blood sugar, does not reflect the frequency of hypoglycemia, does not provide a picture of nighttime glucose drops, and does not indicate the extent of post-meal spikes. Therefore, in some patients, especially those with type 1 diabetes, severe glycemic variability, and insulin therapy, it is necessarily supplemented with self-monitoring of glucose or continuous monitoring. [4]

The current view of this test is that it is a very useful, but not a stand-alone, marker. It aids in the diagnosis of type 2 diabetes and prediabetes, helps monitor the quality of treatment, and helps assess the risk of complications, but it must always be interpreted in conjunction with the clinical picture, routine glucose measurements, and situations that may distort the results. [5]

Table 1. What does glycated hemoglobin show?

Parameter	Practical significance
What is measured	The proportion of hemoglobin bound to glucose
What does it reflect?	Average blood glucose level for approximately 2-3 months
The main role	Diagnosis of prediabetes and type 2 diabetes, treatment monitoring
The main advantage	Does not require fasting and is less dependent on short-term fluctuations
The main limitation	Does not show hypoglycemia, daily fluctuations and can be distorted in a number of conditions

The table is compiled based on current materials from the National Institute of Diabetes, the American Diabetes Association, and standards for assessing glycemia. [6]

When is the test prescribed and how to take it correctly?

Glycated hemoglobin is prescribed in three main situations. The first is screening in people with risk factors for prediabetes and type 2 diabetes. The second is confirming the diagnosis when a carbohydrate metabolism disorder is suspected. The third is regular monitoring in people with established diabetes to determine whether treatment goals have been achieved and whether changes in therapy are necessary. [7]

An important practical advantage of this test is that it doesn't require fasting. Blood can be donated at any time of day, making it convenient for outpatient practice and mass screening. This is why it is widely used as a first laboratory step, especially when assessing persistent rather than one-time hyperglycemia. [8]

If the test is used specifically for diagnostic purposes, the blood must be analyzed in a laboratory using a method that is standardized and comparable to international reference systems. Point-of-care tests performed in a physician's office should not be used for diagnosis. This is a crucial detail that many older articles overlook. [9]

Another diagnostic principle is the need to confirm the result if there are no obvious symptoms of diabetes. If a person's glycated hemoglobin level is accidentally found to be in the diabetic range, the diagnosis is usually confirmed by a repeat test on a different day or another recognized diabetes test. The exception is situations with very high glucose levels and typical symptoms of hyperglycemia, when a repeat test may not be necessary. [10]

If the initial result is normal, the frequency of repeat screening depends on the risk. For individuals without identified abnormalities, repeat testing is often performed at least every 3 years, and more frequently if weight gain or the development of new risk factors occurs. If prediabetes is detected, more regular monitoring is required. [11]

In patients with established diabetes, testing is typically performed at least twice a year if treatment is stable and goals have been achieved. If therapy changes or control remains unsatisfactory, the test is often repeated every 3 months. This interval is not a formality, but rather reflects the biology of red blood cells and the rate at which the indicator actually changes. [12]

Table 2. When to use glycated hemoglobin

Clinical situation	The role of analysis
Screening for risk factors	Detecting prediabetes and type 2 diabetes
Suspected type 2 diabetes	One of the main diagnostic tests
Already established diabetes	Long-term compensation control
Stable treatment	Usually at least twice a year
Change in therapy or poor control	Usually every 3 months
Suspicion of type 1 diabetes or gestational diabetes	Do not use as a primary diagnostic test.

The table is compiled based on materials from the National Diabetes Institute, the American Diabetes Association, and current standards for diabetes management. [13]

Diagnostic thresholds and how to interpret the results

There are generally accepted ranges for diagnosing prediabetes and diabetes. A value below 5.7% is considered normal. A range of 5.7-6.4% indicates prediabetes. A value of 6.5% or higher indicates diabetes, but in the absence of obvious symptoms, this requires confirmation with a repeat measurement or another diagnostic test. [14]

It's important to understand that prediabetes isn't "almost diabetes" in the common sense, but a state of increased risk. The higher the glycated hemoglobin level within this range, the higher the likelihood of progressing to type 2 diabetes. At the same time, cardiovascular risk also increases, so this result cannot be considered a harmless, incidental finding. [15]

The 6.5% threshold is convenient due to its high specificity, but its sensitivity is lower than that of a glucose tolerance test. This means that some people with early carbohydrate metabolism disorders may not yet fall into the diabetic range for glycated hemoglobin, even though other tests indicate diabetes. Therefore, with strong clinical suspicion, a normal or borderline result does not always completely resolve the issue. [16]

In addition to percentages, results are often expressed in millimoles per mole. These are simply two forms of expressing the same value. Internationally, millimoles per mole is increasingly used, while some countries and laboratories continue to express percentages in parallel to make it easier for physicians and patients to understand familiar target values. [17]

Some laboratories also provide an estimated average glucose value. This is an attempt to convert glycated hemoglobin into units of average daily sugar that are familiar to the patient. This value can be useful for communication with the patient, but it remains an estimate and does not replace actual glucose measurements, especially if there is significant sugar variability. [18]

Table 3. Diagnostic ranges

Result	Interpretation
Less than 5.7%	Usually normal
5.7-6.4%	Prediabetes
6.5% and above	Diabetes range
One elevated result without symptoms	Needs confirmation
Normal result with high clinical suspicion	Sometimes requires additional glucose testing

The table is based on the official diagnostic criteria of the American Diabetes Association and the National Institute of Diabetes.[19]

Table 4. Examples of converting the result into different units

Interest	Millimoles per mole	Estimated average glucose
5.0%	31	5.4 mmol per liter
6.0%	42	7.0 mmol per liter
7.0%	53	8.6 mmol per liter
8.0%	64	10.2 mmol per liter
9.0%	75	11.8 mmol per liter
10.0%	86	13.3 mmol per liter

The table is compiled using the international unit conversion table and data on the relationship between glycated hemoglobin and average glucose. [20]

Target values for established diabetes

For most adults with diabetes, a target below 7% is considered a common starting point. This level is used as the primary benchmark in modern standards because it helps reduce the risk of long-term complications while remaining achievable for many patients without excessive risk of hypoglycemia. However, it is not a universal target for everyone. [21]

For adults with type 1 diabetes, UK guidelines also use a target of 48 millimoles per mole (mmol), or 6.5%, or lower if safely achievable. For adults with type 2 diabetes, targets may vary depending on the treatment regimen: in the absence of hypoglycemic medications, 48 millimoles per mole (mmol) is often considered the target, while in treatment with medications that pose a risk of hypoglycemia, 53 millimoles per mole (mmol), or 7.0%, is more often used. [22]

For children and adolescents, goals are also individualized, but current standards indicate that a level below 7% is appropriate for most. For some well-trained and safely monitored patients, a more stringent goal of below 6.5% may be possible if it does not increase the risk of hypoglycemia, impair quality of life, or create undue burden on the family. [23]

For pregnant women, the approach is even stricter, but also more cautious in interpretation. Before conception, it's desirable to aim for a level below 6.5%, and in the second and third trimesters, the lowest risk of adverse outcomes is associated with levels around 6% and below, if this is achieved without problematic hypoglycemia. However, glycated hemoglobin itself is considered a supplementary risk indicator during pregnancy, rather than the best tool for routine monitoring. [24]

In older adults, overly stringent goals can do more harm than good. For relatively healthy elderly patients, a goal of around 7.0-7.5% is possible, while with multiple chronic diseases, cognitive impairment, functional limitations, and high frailty, a goal of up to 8.0% becomes reasonable. In very severe cases, the emphasis shifts from glycated hemoglobin to preventing hypoglycemia and symptomatic hyperglycemia. [25]

Table 5. Treatment goals in different patient groups

Group	A frequent reference point
Most adults with diabetes	Less than 7.0%
Adults with type 1 diabetes	Around 6.5% or lower if safe
Adults with type 2 diabetes without high risk of hypoglycemia	About 6.5%
Adults with type 2 diabetes on therapy at risk of hypoglycemia	About 7.0%
Most children and adolescents	Less than 7.0%
Individual children and adolescents under safe supervision	Less than 6.5%
Relatively well-preserved elderly	Approximately 7.0-7.5%
Elderly people with severe comorbidities or frailty	Up to 8.0%
Before conception	Preferably less than 6.5%
During pregnancy with pre-existing diabetes	About 6.0% or lower if without significant hypoglycemia

The table summarizes current recommendations from the American Diabetes Association, the UK National Institute for Care Excellence, and guidelines for diabetes in pregnancy. [26]

When the result may be false or poorly reflect reality

The most important cause of misinterpretation is a change in the lifespan of red blood cells. If red blood cells have a shorter lifespan than normal, glycated hemoglobin may be lower than the true average glucose level. If they live longer, the value may be higher. Therefore, any conditions that accelerate red blood cell destruction or dramatically renew their population alter the accuracy of the test. [27]

Recent blood loss, blood transfusion, hemolysis, hemodialysis, erythropoietin treatment, and some types of anemia can lead to falsely low or poorly interpreted results. In these conditions, the normal relationship between average glucose and the percentage of glycated hemoglobin is disrupted. In such cases, relying solely on this test is dangerous. [28]

A separate, major topic is hemoglobinopathies and hemoglobin variants. If you carry certain hemoglobin variants or have elevated fetal hemoglobin levels, the accuracy of the test depends on the specific laboratory method. Therefore, if the result deviates from standard sugar measurements, the laboratory and physician must consider the specific method used and how sensitive it is to such interference. [29]

Pregnancy is another situation where interpretation requires caution. During pregnancy, blood physiology changes, so glycated hemoglobin may less accurately reflect current blood glucose levels. Glucose tests are used to diagnose gestational diabetes, usually between 24 and 28 weeks, while glycated hemoglobin is used primarily as an additional risk indicator and to detect previously undetected diabetes early in pregnancy. [30]

In late stages of chronic kidney disease, especially on dialysis, the accuracy of glycated hemoglobin also declines. This is influenced by renal anemia, erythropoietin therapy, carbamylated hemoglobin, and other metabolic characteristics in these patients. However, glycated hemoglobin often remains the primary biomarker, but it is interpreted much more cautiously and supplemented by other glycemic control methods. [31]

Another limitation is that even perfectly measured glycated hemoglobin does not reveal sugar variability and hypoglycemia. Therefore, in patients with frequent glucose drops, significant post-meal spikes, nocturnal episodes, and large discrepancies between self-monitoring and laboratory analysis, additional methods are essential, primarily profile glucose measurements and continuous monitoring. [32]

Table 6. When glycated hemoglobin can be misleading

Situation	What's happening to accuracy?
Recent blood loss	The result may be distorted
Blood transfusion	The result may become unreliable
Hemolysis	A false low reading is possible.
Treatment with erythropoietin	The indicator may be underestimated
Hemodialysis	Reliability is declining
Hemoglobinopathies	Accuracy depends on the method
Pregnancy	For current control the indicator is limited
Late stages of chronic kidney disease	Interpretation is difficult
Inconsistency with self-control results	We need to think about sugar interference or variability.

The table is based on materials from the National Institute of Diabetes, the A1C standardization program, and the chronic kidney disease guidelines. [33]

What to do if the result is elevated and how to use the analysis in practice

If you receive a prediabetes test result for the first time, it's not a reason to panic, but it's also not a time for inaction. At this point, losing weight if you're overweight, increasing physical activity, adjusting your diet, and repeating follow-up testing according to the agreed-upon plan are especially important. Early intervention can indeed reduce the risk of developing type 2 diabetes. [34]

If the result is within the diabetic range, the next step is usually to confirm the diagnosis, unless there are obvious symptoms of hyperglycemia. After confirmation, the doctor evaluates not only the result itself, but also fasting glucose, symptoms, body weight, comorbidities, kidney function, cardiovascular risk, and the likelihood that the test may be distorted. The correct approach always involves more than just one number. [35]

If diabetes has already been diagnosed, glycated hemoglobin is used as a benchmark to address three issues: whether the goal has been achieved, whether therapy needs to be changed, and whether the current treatment is safe enough. If the level rises, the physician typically reviews treatment adherence, nutrition, physical activity, the presence of intercurrent illness, weight changes, and concomitant medications before changing the regimen. [36]

If a result is unexpectedly low or unexpectedly high and does not match routine glucose measurements, it should not be automatically assumed to be accurate. In such a situation, the presence of anemia, blood loss, transfusion, chronic kidney disease, pregnancy, hemoglobinopathy, or erythropoietin therapy should be reconsidered, and whether direct glucose measurements or continuous monitoring would be more appropriate for the specific period. [37]

The key practical takeaway is that glycated hemoglobin is an excellent "long-term" indicator, but it is not the sole decision-making hub. It is most useful when combined with clinical context, self-monitoring of glucose, assessment of hypoglycemia, individual goals, and knowledge of situations where testing can be misleading. This approach is consistent with modern evidence-based diabetology. [38]

FAQ

1. Are glycated hemoglobin and glycosylated hemoglobin the same thing?
In clinical practice, these terms usually refer to the same test, which reflects the proportion of hemoglobin bound to glucose. International sources also use the terms hemoglobin A1c and glycohemoglobin. [39]

2. Do I need to come to the test on an empty stomach?
No, fasting is usually not required for this test. This is one of the main practical advantages of this method. [40]

3. What is a normal result?
For a person without diabetes, a level below 5.7% is usually considered normal. A range of 5.7-6.4% corresponds to prediabetes, and 6.5% and above is considered diabetic. [41]

4. Is one test enough to diagnose diabetes?
Usually not. If there are no obvious symptoms of hyperglycemia, an elevated result should be confirmed with a repeat test or another recognized test. [42]

5. Is this test suitable for diagnosing type 1 diabetes?
No, glycated hemoglobin should not be used as the primary diagnostic test for diagnosing type 1 diabetes. If type 1 diabetes is suspected, direct glucose tests and rapid clinical evaluation are needed. [43]

6. Is this test used to diagnose gestational diabetes?
No. Glucose tests are used for gestational diabetes, usually at 24-28 weeks. During pregnancy, glycated hemoglobin plays a supporting role. [44]

7. How often should diabetes testing be performed if diabetes is already established?
Typically, at least twice a year if the condition is stable. If treatment changes or if goals are not met, testing is often repeated every 3 months. [45]

8. Why can dangerous hypoglycemia still occur even with a good blood sugar test?
Because glycated hemoglobin doesn't reflect daily blood sugar fluctuations and doesn't indicate hypoglycemia. It can appear normal even in someone with frequent blood sugar drops and sharp spikes. [46]

9. Can anemia skew the result?
Yes. Conditions that alter the lifespan of red blood cells, including a number of anemias, blood loss, blood transfusions, hemolysis, and treatment with erythropoietin, can cause the result to be falsely high or falsely low. [47]

10. Which is more important—glycated hemoglobin or normal blood sugar?
These are not competing indicators, but rather complementary ones. Glycated hemoglobin indicates long-term glucose levels, while regular blood sugar measurements and continuous monitoring show current levels, hypoglycemia, and variability. Effective diabetes management requires both approaches. [48]

Conclusion

Glycated hemoglobin remains a key laboratory indicator for detecting prediabetes, diagnosing type 2 diabetes, and monitoring established diabetes. Its main advantages are convenience, no need for fasting, and a good correlation with the risk of long-term complications. [49]

At the same time, this test cannot be interpreted mechanically. It is not suitable for diagnosing type 1 diabetes or gestational diabetes, does not detect hypoglycemia or sugar variability, and can be distorted by anemia, hemoglobinopathies, pregnancy, hemodialysis, and late-stage chronic kidney disease. Therefore, a correct modern interpretation is always individualized and always correlated with the clinical picture and direct glucose measurements. [50]